サルブタモール含有眼科用医薬

Japanese Patent JP7176960

B2

The invention relates to a medicament, the active principle of which is Salbutamol. It can be applied to the prevention and/or treatment of eye diseases or disorders, especially of Ametropia (myopia, Presbyopia), hereditary dystrophies of the retina, glaucoma, cataract, Keratoconus, macular degeneration, diabetic retinopathy, orbital and ocular inflammation (optic neuritis, uveitis), vitreo retinal proliferation or fibrosis, conjunctivitis, dry eye and all the ophthalmic diseases or disorders including a decrease of visual function.

JP2008543751	Aqueous sustained-release drug delivery system for easily water-soluble electrolyte drugs
WO/2015/095713	METHODS OF TREATING NEUROLOGICAL AND OTHER DISORDERS USING ENANTIOPURE DEUTERIUM-ENRICHED BUPROPION
WO/2001/013891	MODULATION OF RELEASE FROM DRY POWDER FORMULATIONS

Raoff Lekiku

JP2018568424A

November 22, 2022

June 27, 2017

Click for automatic bibliography generation  

Raoff Lekiku

A61K31/137; A61K9/06; A61K9/08; A61K9/107; A61K31/192; A61K31/196; A61K31/198; A61K31/401; A61K31/402; A61K31/405; A61K31/421; A61K31/55; A61K31/573; A61K31/585; A61K31/616; A61K31/675; A61K31/7004; A61K33/14; A61K38/05; A61K38/48; A61K45/00; A61P9/10; A61P25/02; A61P27/02; A61P27/04; A61P27/06; A61P27/10; A61P27/12; A61P27/14; A61P29/00; A61P43/00

JP2013544275A
JP1502829A
JP2005516914A
JP2013527222A

WO2011068786A1
WO2001041806A1
US3985897
WO2010125416A1

Murayama Yasuhiko
Shinya Mihiro
Tatsuhiko Abe

Previous Patent: Terminal, wireless communication method and system

Next Patent: rear combination lamp